Evaluation of Dosing Interval of Higher Doses of Ranibizumab (BGB/IST)
This study is ongoing, but not recruiting participants.
Sponsor:
Brandon G. Busbee, MD
Collaborator:
Genentech
Information provided by (Responsible Party):
Brandon G. Busbee, MD, Tennessee Retina
ClinicalTrials.gov Identifier:
NCT00533520
First received: September 19, 2007
Last updated: May 23, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | November 2013 (Final data collection date for primary outcome measure) |